ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel Article (Faculty180)

cited authors

  • Sissung, Tristan M; Baum, Caitlin E; Deeken, John; Price, Douglas K; Aragon-Ching, Jeanny; Steinberg, Seth M; Dahut, William; Sparreboom, Alex; Figg, William D

description

  • Polymorphisms that are associated with ABCB1 expression and function may be linked to treatment efficacy and the development of neutropenia and neurotoxicity in patients with androgen-independent prostate cancer receiving docetaxel.

authors

publication date

  • 2008

published in

start page

  • 4543

end page

  • 9

volume

  • 14